These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23903225)

  • 1. [Chemistry of amide-based axial chirality: elucidation of the active conformation recognized by enzymes and receptors].
    Tabata H
    Yakugaku Zasshi; 2013; 133(8):857-66. PubMed ID: 23903225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active conformation of seven-membered-ring benzolactams as new ACAT inhibitors: latent chirality at N5 in the 1,5-benzodiazepin-2-one nucleus.
    Tabata H; Wada N; Takada Y; Nakagomi J; Miike T; Shirahase H; Oshitari T; Takahashi H; Natsugari H
    Chemistry; 2012 Feb; 18(6):1572-6. PubMed ID: 22213135
    [No Abstract]   [Full Text] [Related]  

  • 3. Atropisomerism in the Pharmaceutically Relevant Realm.
    Basilaia M; Chen MH; Secka J; Gustafson JL
    Acc Chem Res; 2022 Oct; 55(20):2904-2919. PubMed ID: 36153960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axial chirality and affinity at the GABA(A) receptor of pyrimido[1,2-a][1,4]benzodiazepines and related compounds.
    Lee S; Kamide T; Tabata H; Takahashi H; Shiro M; Natsugari H
    Bioorg Med Chem; 2008 Nov; 16(21):9519-23. PubMed ID: 18829330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iridium catalyzed asymmetric hydrogenation of cyclic imines of benzodiazepinones and benzodiazepines.
    Gao K; Wu B; Yu CB; Chen QA; Ye ZS; Zhou YG
    Org Lett; 2012 Aug; 14(15):3890-3. PubMed ID: 22799531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atropisomerism in the vaptan class of vasopressin receptor ligands: the active conformation recognized by the receptor.
    Tabata H; Nakagomi J; Morizono D; Oshitari T; Takahashi H; Natsugari H
    Angew Chem Int Ed Engl; 2011 Mar; 50(13):3075-9. PubMed ID: 21404400
    [No Abstract]   [Full Text] [Related]  

  • 7. N-benzoyl-1,5-benzothiazepine and its S-oxide as vasopressin receptor ligands: insight into the active stereochemistry around the seven-membered ring.
    Yoneda T; Tabata H; Tasaka T; Oshitari T; Takahashi H; Natsugari H
    J Med Chem; 2015 Apr; 58(7):3268-73. PubMed ID: 25774991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatographic resolution of 3-amino-1,4-benzodiazepin-2-one derivatives on various Pirkle-type chiral stationary phases.
    Park JY; Cho HS; Hyun MH
    Chirality; 2011; 23 Suppl 1():E16-21. PubMed ID: 21365690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-benzoyl- and N-sulfonyl-1,5-benzodiazepines: comparison of their atropisomeric and conformational properties.
    Yoneda T; Tabata H; Nakagomi J; Tasaka T; Oshitari T; Takahashi H; Natsugari H
    J Org Chem; 2014 Jun; 79(12):5717-27. PubMed ID: 24837605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Ar-BINMOL-Derived Atropisomeric Ligands with Matched Axial and sp(3) Central Chirality for Catalytic Asymmetric Transformations.
    Xu Z; Xu LW
    Chem Rec; 2015 Oct; 15(5):925-48. PubMed ID: 26400411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of the Active Conformation of Antiproliferative Sulfonamides, 5
    Tabata H; Funaki K; Tasaka T; Oshitari T; Takahashi H; Natsugari H
    J Org Chem; 2019 Dec; 84(24):16338-16345. PubMed ID: 31765150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolvaptan-Type Vasopressin Receptor Ligands: Important Role of Axial Chirality in the Active Form.
    Tabata H; Yoneda T; Oshitari T; Takahashi H; Natsugari H
    J Med Chem; 2017 May; 60(10):4503-4509. PubMed ID: 28475329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress toward developing axial chirality bioactive compounds.
    Wang Z; Meng L; Liu X; Zhang L; Yu Z; Wu G
    Eur J Med Chem; 2022 Dec; 243():114700. PubMed ID: 36058089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent encounters with atropisomerism in drug discovery.
    Glunz PW
    Bioorg Med Chem Lett; 2018 Jan; 28(2):53-60. PubMed ID: 29223590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atropisomerism in Drug Discovery: A Medicinal Chemistry Perspective Inspired by Atropisomeric Class I PI3K Inhibitors.
    Perreault S; Chandrasekhar J; Patel L
    Acc Chem Res; 2022 Sep; 55(18):2581-2593. PubMed ID: 36069734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of Configurationally Stable Atropoenantiomers in Macrocyclic Natural Products and the Chrysophaentin Family.
    Bewley CA; Sulikowski GA; Yang ZJ; Bifulco G; Cho HM; Fullenkamp CR
    Acc Chem Res; 2023 Feb; 56(4):414-424. PubMed ID: 36731116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atropisomerism transforming anti-cancer drug discovery.
    Patel S; Sandha K; Waingankar A; Jain P; Abhyankar A
    Chem Biol Drug Des; 2023 Jan; 101(1):138-157. PubMed ID: 36254625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nonneglectable stereochemical factor in drug development: Atropisomerism.
    Yang YD; Yang BB; Li L
    Chirality; 2022 Oct; 34(10):1355-1370. PubMed ID: 35904531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable C-N axial chirality in 1-aryluracil scaffold and differences in in vitro metabolic clearance between atropisomers of PDE4 inhibitor.
    Hasegawa F; Kawamura K; Tsuchikawa H; Murata M
    Bioorg Med Chem; 2017 Aug; 25(16):4506-4511. PubMed ID: 28698053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational preferences in a benzodiazepine series of potent nonpeptide fibrinogen receptor antagonists.
    Keenan RM; Callahan JF; Samanen JM; Bondinell WE; Calvo RR; Chen L; DeBrosse C; Eggleston DS; Haltiwanger RC; Hwang SM; Jakas DR; Ku TW; Miller WH; Newlander KA; Nichols A; Parker MF; Southhall LS; Uzinskas I; Vasko-Moser JA; Venslavsky JW; Wong AS; Huffman WF
    J Med Chem; 1999 Feb; 42(4):545-59. PubMed ID: 10052962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.